nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitrofurantoin—ABCG2—Dexamethasone—psoriatic arthritis	0.22	0.554	CbGbCtD
Nitrofurantoin—ABCG2—Methotrexate—psoriatic arthritis	0.177	0.446	CbGbCtD
Nitrofurantoin—Benign intracranial hypertension—Dexamethasone—psoriatic arthritis	0.00978	0.0162	CcSEcCtD
Nitrofurantoin—Benign intracranial hypertension—Betamethasone—psoriatic arthritis	0.00978	0.0162	CcSEcCtD
Nitrofurantoin—Anaemia megaloblastic—Methotrexate—psoriatic arthritis	0.00888	0.0147	CcSEcCtD
Nitrofurantoin—Benign intracranial hypertension—Prednisone—psoriatic arthritis	0.00852	0.0141	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Auranofin—psoriatic arthritis	0.00832	0.0138	CcSEcCtD
Nitrofurantoin—Electrolyte imbalance—Methylprednisolone—psoriatic arthritis	0.00757	0.0126	CcSEcCtD
Nitrofurantoin—Fibrosis—Methotrexate—psoriatic arthritis	0.00732	0.0122	CcSEcCtD
Nitrofurantoin—Electrolyte imbalance—Dexamethasone—psoriatic arthritis	0.00688	0.0114	CcSEcCtD
Nitrofurantoin—Electrolyte imbalance—Betamethasone—psoriatic arthritis	0.00688	0.0114	CcSEcCtD
Nitrofurantoin—Eosinophilia—Auranofin—psoriatic arthritis	0.00671	0.0111	CcSEcCtD
Nitrofurantoin—Reaction gastrointestinal—Methotrexate—psoriatic arthritis	0.00627	0.0104	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Auranofin—psoriatic arthritis	0.00593	0.00983	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Auranofin—psoriatic arthritis	0.00564	0.00936	CcSEcCtD
Nitrofurantoin—Optic neuritis—Prednisolone—psoriatic arthritis	0.0056	0.0093	CcSEcCtD
Nitrofurantoin—Optic neuritis—Triamcinolone—psoriatic arthritis	0.00515	0.00855	CcSEcCtD
Nitrofurantoin—Optic neuritis—Methylprednisolone—psoriatic arthritis	0.00514	0.00853	CcSEcCtD
Nitrofurantoin—Alopecia—Auranofin—psoriatic arthritis	0.0048	0.00796	CcSEcCtD
Nitrofurantoin—Optic neuritis—Dexamethasone—psoriatic arthritis	0.00468	0.00776	CcSEcCtD
Nitrofurantoin—Optic neuritis—Betamethasone—psoriatic arthritis	0.00468	0.00776	CcSEcCtD
Nitrofurantoin—Flatulence—Auranofin—psoriatic arthritis	0.00466	0.00773	CcSEcCtD
Nitrofurantoin—Lung infiltration—Methotrexate—psoriatic arthritis	0.00446	0.00741	CcSEcCtD
Nitrofurantoin—Anaemia—Auranofin—psoriatic arthritis	0.00437	0.00725	CcSEcCtD
Nitrofurantoin—Interstitial pneumonia—Methotrexate—psoriatic arthritis	0.00433	0.00719	CcSEcCtD
Nitrofurantoin—Leukopenia—Auranofin—psoriatic arthritis	0.00423	0.00702	CcSEcCtD
Nitrofurantoin—Optic neuritis—Prednisone—psoriatic arthritis	0.00407	0.00676	CcSEcCtD
Nitrofurantoin—Tingling sensation—Methylprednisolone—psoriatic arthritis	0.00393	0.00653	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00378	0.00626	CcSEcCtD
Nitrofurantoin—Anorexia—Auranofin—psoriatic arthritis	0.00368	0.0061	CcSEcCtD
Nitrofurantoin—Tingling sensation—Betamethasone—psoriatic arthritis	0.00358	0.00594	CcSEcCtD
Nitrofurantoin—Tingling sensation—Dexamethasone—psoriatic arthritis	0.00358	0.00594	CcSEcCtD
Nitrofurantoin—Vasculitis—Prednisolone—psoriatic arthritis	0.00353	0.00586	CcSEcCtD
Nitrofurantoin—Eruption—Methotrexate—psoriatic arthritis	0.0034	0.00565	CcSEcCtD
Nitrofurantoin—Dyspepsia—Auranofin—psoriatic arthritis	0.00339	0.00563	CcSEcCtD
Nitrofurantoin—Decreased appetite—Auranofin—psoriatic arthritis	0.00335	0.00556	CcSEcCtD
Nitrofurantoin—Constipation—Auranofin—psoriatic arthritis	0.0033	0.00547	CcSEcCtD
Nitrofurantoin—Vasculitis—Triamcinolone—psoriatic arthritis	0.00325	0.00539	CcSEcCtD
Nitrofurantoin—Vasculitis—Methylprednisolone—psoriatic arthritis	0.00324	0.00538	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00315	0.00523	CcSEcCtD
Nitrofurantoin—Liver disorder—Methotrexate—psoriatic arthritis	0.00307	0.00509	CcSEcCtD
Nitrofurantoin—Abdominal pain—Auranofin—psoriatic arthritis	0.00305	0.00506	CcSEcCtD
Nitrofurantoin—Euphoric mood—Prednisolone—psoriatic arthritis	0.00296	0.00491	CcSEcCtD
Nitrofurantoin—Interstitial lung disease—Methotrexate—psoriatic arthritis	0.00296	0.00491	CcSEcCtD
Nitrofurantoin—Cyanosis—Methotrexate—psoriatic arthritis	0.00296	0.00491	CcSEcCtD
Nitrofurantoin—Vasculitis—Dexamethasone—psoriatic arthritis	0.00295	0.00489	CcSEcCtD
Nitrofurantoin—Vasculitis—Betamethasone—psoriatic arthritis	0.00295	0.00489	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Prednisolone—psoriatic arthritis	0.00288	0.00477	CcSEcCtD
Nitrofurantoin—Pleural effusion—Methotrexate—psoriatic arthritis	0.00273	0.00453	CcSEcCtD
Nitrofurantoin—Euphoric mood—Triamcinolone—psoriatic arthritis	0.00272	0.00452	CcSEcCtD
Nitrofurantoin—Euphoric mood—Methylprednisolone—psoriatic arthritis	0.00272	0.00451	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Triamcinolone—psoriatic arthritis	0.00265	0.00439	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Methylprednisolone—psoriatic arthritis	0.00264	0.00438	CcSEcCtD
Nitrofurantoin—Diarrhoea—Auranofin—psoriatic arthritis	0.00264	0.00438	CcSEcCtD
Nitrofurantoin—Vasculitis—Prednisone—psoriatic arthritis	0.00257	0.00426	CcSEcCtD
Nitrofurantoin—Euphoric mood—Betamethasone—psoriatic arthritis	0.00247	0.0041	CcSEcCtD
Nitrofurantoin—Euphoric mood—Dexamethasone—psoriatic arthritis	0.00247	0.0041	CcSEcCtD
Nitrofurantoin—Vomiting—Auranofin—psoriatic arthritis	0.00245	0.00407	CcSEcCtD
Nitrofurantoin—Rash—Auranofin—psoriatic arthritis	0.00243	0.00403	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Dexamethasone—psoriatic arthritis	0.0024	0.00398	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Betamethasone—psoriatic arthritis	0.0024	0.00398	CcSEcCtD
Nitrofurantoin—Nausea—Auranofin—psoriatic arthritis	0.00229	0.0038	CcSEcCtD
Nitrofurantoin—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00224	0.00372	CcSEcCtD
Nitrofurantoin—Euphoric mood—Prednisone—psoriatic arthritis	0.00215	0.00357	CcSEcCtD
Nitrofurantoin—Vasculitis—Methotrexate—psoriatic arthritis	0.00214	0.00356	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Prednisone—psoriatic arthritis	0.00209	0.00347	CcSEcCtD
Nitrofurantoin—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00204	0.00338	CcSEcCtD
Nitrofurantoin—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00204	0.00338	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.00202	0.00336	CcSEcCtD
Nitrofurantoin—Asthma—Triamcinolone—psoriatic arthritis	0.00199	0.0033	CcSEcCtD
Nitrofurantoin—Aplastic anaemia—Methotrexate—psoriatic arthritis	0.00197	0.00326	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.00189	0.00314	CcSEcCtD
Nitrofurantoin—Psychotic disorder—Prednisone—psoriatic arthritis	0.00178	0.00295	CcSEcCtD
Nitrofurantoin—Diabetes mellitus—Methotrexate—psoriatic arthritis	0.00175	0.0029	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.00174	0.00288	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.00173	0.00288	CcSEcCtD
Nitrofurantoin—Dermatitis exfoliative—Methotrexate—psoriatic arthritis	0.00161	0.00267	CcSEcCtD
Nitrofurantoin—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.0016	0.00266	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.00158	0.00262	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.00158	0.00262	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.0014	0.00232	CcSEcCtD
Nitrofurantoin—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00137	0.00228	CcSEcCtD
Nitrofurantoin—Malaise—Prednisolone—psoriatic arthritis	0.00136	0.00225	CcSEcCtD
Nitrofurantoin—Vertigo—Prednisolone—psoriatic arthritis	0.00135	0.00225	CcSEcCtD
Nitrofurantoin—Asthma—Methotrexate—psoriatic arthritis	0.00131	0.00218	CcSEcCtD
Nitrofurantoin—Eosinophilia—Methotrexate—psoriatic arthritis	0.0013	0.00216	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.00129	0.00213	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.00128	0.00213	CcSEcCtD
Nitrofurantoin—Alopecia—Betamethasone—psoriatic arthritis	0.00128	0.00212	CcSEcCtD
Nitrofurantoin—Alopecia—Dexamethasone—psoriatic arthritis	0.00128	0.00212	CcSEcCtD
Nitrofurantoin—Discomfort—Prednisolone—psoriatic arthritis	0.00127	0.0021	CcSEcCtD
Nitrofurantoin—Malaise—Triamcinolone—psoriatic arthritis	0.00125	0.00207	CcSEcCtD
Nitrofurantoin—Malaise—Methylprednisolone—psoriatic arthritis	0.00125	0.00207	CcSEcCtD
Nitrofurantoin—Vertigo—Triamcinolone—psoriatic arthritis	0.00124	0.00207	CcSEcCtD
Nitrofurantoin—Vertigo—Methylprednisolone—psoriatic arthritis	0.00124	0.00206	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00123	0.00204	CcSEcCtD
Nitrofurantoin—Cough—Triamcinolone—psoriatic arthritis	0.00121	0.00201	CcSEcCtD
Nitrofurantoin—Myalgia—Triamcinolone—psoriatic arthritis	0.00118	0.00196	CcSEcCtD
Nitrofurantoin—Myalgia—Methylprednisolone—psoriatic arthritis	0.00118	0.00195	CcSEcCtD
Nitrofurantoin—Drowsiness—Methotrexate—psoriatic arthritis	0.00117	0.00194	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.00117	0.00194	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.00117	0.00194	CcSEcCtD
Nitrofurantoin—Discomfort—Triamcinolone—psoriatic arthritis	0.00117	0.00193	CcSEcCtD
Nitrofurantoin—Discomfort—Methylprednisolone—psoriatic arthritis	0.00116	0.00193	CcSEcCtD
Nitrofurantoin—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00116	0.00193	CcSEcCtD
Nitrofurantoin—Renal failure—Methotrexate—psoriatic arthritis	0.00115	0.00191	CcSEcCtD
Nitrofurantoin—Confusional state—Methylprednisolone—psoriatic arthritis	0.00114	0.00189	CcSEcCtD
Nitrofurantoin—Malaise—Dexamethasone—psoriatic arthritis	0.00113	0.00188	CcSEcCtD
Nitrofurantoin—Malaise—Betamethasone—psoriatic arthritis	0.00113	0.00188	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00113	0.00188	CcSEcCtD
Nitrofurantoin—Vertigo—Dexamethasone—psoriatic arthritis	0.00113	0.00187	CcSEcCtD
Nitrofurantoin—Vertigo—Betamethasone—psoriatic arthritis	0.00113	0.00187	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00113	0.00187	CcSEcCtD
Nitrofurantoin—Alopecia—Prednisone—psoriatic arthritis	0.00111	0.00184	CcSEcCtD
Nitrofurantoin—Paraesthesia—Prednisolone—psoriatic arthritis	0.0011	0.00183	CcSEcCtD
Nitrofurantoin—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00109	0.00181	CcSEcCtD
Nitrofurantoin—Myalgia—Betamethasone—psoriatic arthritis	0.00107	0.00178	CcSEcCtD
Nitrofurantoin—Myalgia—Dexamethasone—psoriatic arthritis	0.00107	0.00178	CcSEcCtD
Nitrofurantoin—Discomfort—Dexamethasone—psoriatic arthritis	0.00106	0.00175	CcSEcCtD
Nitrofurantoin—Discomfort—Betamethasone—psoriatic arthritis	0.00106	0.00175	CcSEcCtD
Nitrofurantoin—Hepatitis—Methotrexate—psoriatic arthritis	0.00105	0.00174	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00103	0.00171	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00103	0.00171	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00103	0.0017	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00103	0.0017	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Prednisone—psoriatic arthritis	0.00102	0.00169	CcSEcCtD
Nitrofurantoin—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00102	0.00168	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00101	0.00168	CcSEcCtD
Nitrofurantoin—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00101	0.00168	CcSEcCtD
Nitrofurantoin—Anaemia—Prednisone—psoriatic arthritis	0.00101	0.00168	CcSEcCtD
Nitrofurantoin—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00101	0.00167	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.001	0.00167	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.001	0.00167	CcSEcCtD
Nitrofurantoin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000995	0.00165	CcSEcCtD
Nitrofurantoin—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000994	0.00165	CcSEcCtD
Nitrofurantoin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000993	0.00165	CcSEcCtD
Nitrofurantoin—Malaise—Prednisone—psoriatic arthritis	0.000987	0.00164	CcSEcCtD
Nitrofurantoin—Vertigo—Prednisone—psoriatic arthritis	0.000984	0.00163	CcSEcCtD
Nitrofurantoin—Anorexia—Betamethasone—psoriatic arthritis	0.000978	0.00162	CcSEcCtD
Nitrofurantoin—Anorexia—Dexamethasone—psoriatic arthritis	0.000978	0.00162	CcSEcCtD
Nitrofurantoin—Chills—Methotrexate—psoriatic arthritis	0.000943	0.00156	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000935	0.00155	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000935	0.00155	CcSEcCtD
Nitrofurantoin—Myalgia—Prednisone—psoriatic arthritis	0.000932	0.00155	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000932	0.00155	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00093	0.00154	CcSEcCtD
Nitrofurantoin—Alopecia—Methotrexate—psoriatic arthritis	0.000929	0.00154	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000923	0.00153	CcSEcCtD
Nitrofurantoin—Paraesthesia—Betamethasone—psoriatic arthritis	0.000921	0.00153	CcSEcCtD
Nitrofurantoin—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000921	0.00153	CcSEcCtD
Nitrofurantoin—Discomfort—Prednisone—psoriatic arthritis	0.000921	0.00153	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000906	0.0015	CcSEcCtD
Nitrofurantoin—Dyspepsia—Betamethasone—psoriatic arthritis	0.000903	0.0015	CcSEcCtD
Nitrofurantoin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000903	0.0015	CcSEcCtD
Nitrofurantoin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000894	0.00148	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000894	0.00148	CcSEcCtD
Nitrofurantoin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000892	0.00148	CcSEcCtD
Nitrofurantoin—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000892	0.00148	CcSEcCtD
Nitrofurantoin—Decreased appetite—Betamethasone—psoriatic arthritis	0.000892	0.00148	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000886	0.00147	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000886	0.00147	CcSEcCtD
Nitrofurantoin—Anorexia—Prednisone—psoriatic arthritis	0.000852	0.00141	CcSEcCtD
Nitrofurantoin—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000849	0.00141	CcSEcCtD
Nitrofurantoin—Anaemia—Methotrexate—psoriatic arthritis	0.000846	0.0014	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000845	0.0014	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000845	0.0014	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000839	0.00139	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000839	0.00139	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000833	0.00138	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000831	0.00138	CcSEcCtD
Nitrofurantoin—Malaise—Methotrexate—psoriatic arthritis	0.000825	0.00137	CcSEcCtD
Nitrofurantoin—Vertigo—Methotrexate—psoriatic arthritis	0.000822	0.00136	CcSEcCtD
Nitrofurantoin—Leukopenia—Methotrexate—psoriatic arthritis	0.000819	0.00136	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000814	0.00135	CcSEcCtD
Nitrofurantoin—Dizziness—Prednisolone—psoriatic arthritis	0.000813	0.00135	CcSEcCtD
Nitrofurantoin—Asthenia—Triamcinolone—psoriatic arthritis	0.000811	0.00135	CcSEcCtD
Nitrofurantoin—Abdominal pain—Betamethasone—psoriatic arthritis	0.000811	0.00135	CcSEcCtD
Nitrofurantoin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000811	0.00135	CcSEcCtD
Nitrofurantoin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000811	0.00135	CcSEcCtD
Nitrofurantoin—Body temperature increased—Betamethasone—psoriatic arthritis	0.000811	0.00135	CcSEcCtD
Nitrofurantoin—Asthenia—Methylprednisolone—psoriatic arthritis	0.000809	0.00134	CcSEcCtD
Nitrofurantoin—Paraesthesia—Prednisone—psoriatic arthritis	0.000802	0.00133	CcSEcCtD
Nitrofurantoin—Cough—Methotrexate—psoriatic arthritis	0.000798	0.00132	CcSEcCtD
Nitrofurantoin—Dyspepsia—Prednisone—psoriatic arthritis	0.000787	0.0013	CcSEcCtD
Nitrofurantoin—Chest pain—Methotrexate—psoriatic arthritis	0.000779	0.00129	CcSEcCtD
Nitrofurantoin—Myalgia—Methotrexate—psoriatic arthritis	0.000779	0.00129	CcSEcCtD
Nitrofurantoin—Decreased appetite—Prednisone—psoriatic arthritis	0.000777	0.00129	CcSEcCtD
Nitrofurantoin—Rash—Prednisolone—psoriatic arthritis	0.000775	0.00129	CcSEcCtD
Nitrofurantoin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000772	0.00128	CcSEcCtD
Nitrofurantoin—Headache—Prednisolone—psoriatic arthritis	0.00077	0.00128	CcSEcCtD
Nitrofurantoin—Discomfort—Methotrexate—psoriatic arthritis	0.00077	0.00128	CcSEcCtD
Nitrofurantoin—Constipation—Prednisone—psoriatic arthritis	0.000764	0.00127	CcSEcCtD
Nitrofurantoin—Confusional state—Methotrexate—psoriatic arthritis	0.000753	0.00125	CcSEcCtD
Nitrofurantoin—Dizziness—Triamcinolone—psoriatic arthritis	0.000748	0.00124	CcSEcCtD
Nitrofurantoin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000747	0.00124	CcSEcCtD
Nitrofurantoin—Dizziness—Methylprednisolone—psoriatic arthritis	0.000746	0.00124	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Prednisone—psoriatic arthritis	0.000736	0.00122	CcSEcCtD
Nitrofurantoin—Asthenia—Dexamethasone—psoriatic arthritis	0.000736	0.00122	CcSEcCtD
Nitrofurantoin—Asthenia—Betamethasone—psoriatic arthritis	0.000736	0.00122	CcSEcCtD
Nitrofurantoin—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000731	0.00121	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000731	0.00121	CcSEcCtD
Nitrofurantoin—Nausea—Prednisolone—psoriatic arthritis	0.00073	0.00121	CcSEcCtD
Nitrofurantoin—Vomiting—Triamcinolone—psoriatic arthritis	0.000719	0.00119	CcSEcCtD
Nitrofurantoin—Vomiting—Methylprednisolone—psoriatic arthritis	0.000717	0.00119	CcSEcCtD
Nitrofurantoin—Rash—Triamcinolone—psoriatic arthritis	0.000713	0.00118	CcSEcCtD
Nitrofurantoin—Anorexia—Methotrexate—psoriatic arthritis	0.000712	0.00118	CcSEcCtD
Nitrofurantoin—Rash—Methylprednisolone—psoriatic arthritis	0.000711	0.00118	CcSEcCtD
Nitrofurantoin—Headache—Triamcinolone—psoriatic arthritis	0.000708	0.00118	CcSEcCtD
Nitrofurantoin—Headache—Methylprednisolone—psoriatic arthritis	0.000707	0.00117	CcSEcCtD
Nitrofurantoin—Abdominal pain—Prednisone—psoriatic arthritis	0.000706	0.00117	CcSEcCtD
Nitrofurantoin—Body temperature increased—Prednisone—psoriatic arthritis	0.000706	0.00117	CcSEcCtD
Nitrofurantoin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000702	0.00116	CcSEcCtD
Nitrofurantoin—Diarrhoea—Betamethasone—psoriatic arthritis	0.000702	0.00116	CcSEcCtD
Nitrofurantoin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00068	0.00113	CcSEcCtD
Nitrofurantoin—Dizziness—Dexamethasone—psoriatic arthritis	0.000678	0.00113	CcSEcCtD
Nitrofurantoin—Dizziness—Betamethasone—psoriatic arthritis	0.000678	0.00113	CcSEcCtD
Nitrofurantoin—Nausea—Triamcinolone—psoriatic arthritis	0.000672	0.00111	CcSEcCtD
Nitrofurantoin—Paraesthesia—Methotrexate—psoriatic arthritis	0.000671	0.00111	CcSEcCtD
Nitrofurantoin—Nausea—Methylprednisolone—psoriatic arthritis	0.00067	0.00111	CcSEcCtD
Nitrofurantoin—Dyspnoea—Methotrexate—psoriatic arthritis	0.000666	0.0011	CcSEcCtD
Nitrofurantoin—Somnolence—Methotrexate—psoriatic arthritis	0.000664	0.0011	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Prednisone—psoriatic arthritis	0.000658	0.00109	CcSEcCtD
Nitrofurantoin—Dyspepsia—Methotrexate—psoriatic arthritis	0.000657	0.00109	CcSEcCtD
Nitrofurantoin—Vomiting—Dexamethasone—psoriatic arthritis	0.000652	0.00108	CcSEcCtD
Nitrofurantoin—Vomiting—Betamethasone—psoriatic arthritis	0.000652	0.00108	CcSEcCtD
Nitrofurantoin—Decreased appetite—Methotrexate—psoriatic arthritis	0.000649	0.00108	CcSEcCtD
Nitrofurantoin—Rash—Betamethasone—psoriatic arthritis	0.000647	0.00107	CcSEcCtD
Nitrofurantoin—Rash—Dexamethasone—psoriatic arthritis	0.000647	0.00107	CcSEcCtD
Nitrofurantoin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000645	0.00107	CcSEcCtD
Nitrofurantoin—Headache—Betamethasone—psoriatic arthritis	0.000643	0.00107	CcSEcCtD
Nitrofurantoin—Headache—Dexamethasone—psoriatic arthritis	0.000643	0.00107	CcSEcCtD
Nitrofurantoin—Asthenia—Prednisone—psoriatic arthritis	0.000641	0.00106	CcSEcCtD
Nitrofurantoin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000615	0.00102	CcSEcCtD
Nitrofurantoin—Diarrhoea—Prednisone—psoriatic arthritis	0.000611	0.00101	CcSEcCtD
Nitrofurantoin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000611	0.00101	CcSEcCtD
Nitrofurantoin—Nausea—Betamethasone—psoriatic arthritis	0.000609	0.00101	CcSEcCtD
Nitrofurantoin—Nausea—Dexamethasone—psoriatic arthritis	0.000609	0.00101	CcSEcCtD
Nitrofurantoin—Dizziness—Prednisone—psoriatic arthritis	0.000591	0.00098	CcSEcCtD
Nitrofurantoin—Abdominal pain—Methotrexate—psoriatic arthritis	0.00059	0.000979	CcSEcCtD
Nitrofurantoin—Body temperature increased—Methotrexate—psoriatic arthritis	0.00059	0.000979	CcSEcCtD
Nitrofurantoin—Vomiting—Prednisone—psoriatic arthritis	0.000568	0.000943	CcSEcCtD
Nitrofurantoin—Rash—Prednisone—psoriatic arthritis	0.000563	0.000935	CcSEcCtD
Nitrofurantoin—Headache—Prednisone—psoriatic arthritis	0.00056	0.000929	CcSEcCtD
Nitrofurantoin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00055	0.000913	CcSEcCtD
Nitrofurantoin—Asthenia—Methotrexate—psoriatic arthritis	0.000536	0.000889	CcSEcCtD
Nitrofurantoin—Nausea—Prednisone—psoriatic arthritis	0.000531	0.000881	CcSEcCtD
Nitrofurantoin—Diarrhoea—Methotrexate—psoriatic arthritis	0.000511	0.000848	CcSEcCtD
Nitrofurantoin—Dizziness—Methotrexate—psoriatic arthritis	0.000494	0.000819	CcSEcCtD
Nitrofurantoin—Vomiting—Methotrexate—psoriatic arthritis	0.000475	0.000788	CcSEcCtD
Nitrofurantoin—Rash—Methotrexate—psoriatic arthritis	0.000471	0.000781	CcSEcCtD
Nitrofurantoin—Headache—Methotrexate—psoriatic arthritis	0.000468	0.000776	CcSEcCtD
Nitrofurantoin—Nausea—Methotrexate—psoriatic arthritis	0.000444	0.000736	CcSEcCtD
